Seda are delighted to announce The Medicines and Healthcare products Regulatory Agency (MHRA) approval of our Good Manufacturing Practice (GMP) Manufacturer’s Authorisation. 

The MHRA has officially granted Seda a GMP license, marking a significant milestone in Seda’s company growth since its inception. 

The GMP license has been awarded after rigorous inspections and compliance checks, ensuring that we meet the highest standards of quality and safety in the production of medicinal products. This approval not only enhances our credibility but also opens new avenues to accelerate our clients’ transition into and through the clinical phases of development by providing GMP product and associated testing of the very highest quality. 

The GMP license will allow us to combine the expertise of our development and manufacturing divisions, positioning ourselves as a trusted partner, supporting our clients throughout their entire development journey. Offering a seamless transition from development into clinic. 

The MHRA’s GMP certification is a testament to the Seda team and our dedication to quality and regulatory compliance. It reflects our ongoing efforts to adhere to stringent manufacturing practices and ensure the consistent production of high-quality medicinal products. 

CEO Paul Stott commented ‘This marks the transition of Seda into a full service CDMO. I am incredibly proud of what the team has achieved and excited to see the evolution of our service offering. Thanks to everyone who has supported us along the way.’ 

To find out further information about our capabilities following our GMP authorisation take a look at our Clinical Manufacturing Services website or contact us to find out more about how we can support your programme.